A detailed history of Pictet Asset Management Holding Sa transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 27,957 shares of ADMA stock, worth $592,129. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,957
Previous 31,331 10.77%
Holding current value
$592,129
Previous $350,000 59.43%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$11.21 - $20.03 $37,822 - $67,581
-3,374 Reduced 10.77%
27,957 $558,000
Q1 2024

May 14, 2024

BUY
$4.4 - $6.74 $16,346 - $25,039
3,715 Added 13.45%
31,331 $206,000
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $39,793 - $58,398
12,920 Added 87.92%
27,616 $124,000
Q3 2023

Nov 14, 2023

BUY
$3.47 - $4.61 $50,995 - $67,748
14,696 New
14,696 $52,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.